新型糖尿病控制藥物！腸泌素GLP-1
US$ 29.65
retatrutide clinical trials status 2025 The Dosage Chart CutKilo | Retatrutide - what
Description
There is a lot of discussion about people potentially taking GLP-1s for life for the cardiovascular health benefits
AONs GLP-1 Study Is a Warning Shot and an Opening A 44% drop in heart events
A worrying amount of people are able to get hold of it
Lilly and other followers will need to generate their own evidence to support cardiovascular benefits of their own obesity treatments to compete on coverage and use
